Free Trial
→ Stranded On The Flood Plains of History (From Porter & Company) (Ad)tc pixel Free ENVB Stock Alerts

Enveric Biosciences (ENVB) Short Interest Ratio & Short Volume

Enveric Biosciences logo
$2.00 +0.02 (+0.76%)
As of 03:26 PM Eastern
This is a fair market value price provided by Massive. Learn more.
Compare

Enveric Biosciences Short Interest Overview

As of May 15, 2026, Enveric Biosciences (ENVB) had a short interest of 115,974 shares sold short, representing 3.23% of the public float. This marks a -86.92% decrease in short interest since the prior report. The short interest ratio (days to cover) is 0.3, meaning it would take 0.3 days of the average trading volume of 2.46 million shares to cover all short positions.

Current Short Interest
115,974 shares
Previous Short Interest
886,509 shares
Change Vs. Previous Month
-86.92%
Dollar Volume Sold Short
$260.94 thousand
Short Interest Ratio
0.3 Days to Cover
Last Record Date
May 15, 2026
Outstanding Shares
3,680,000 shares
Short Percent of Float
3.23%
Today's Trading Volume
67,309 shares
Average Trading Volume
2,461,078 shares
Today's Volume Vs. Average
3%
Short Selling Enveric Biosciences?
A Guide To High-Short-Interest Stocks

Sign up to receive the latest short interest report for Enveric Biosciences and its competitors with MarketBeat's FREE newsletter.

Get Report
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Charts & View Short Interest History
Short Interest ChartDays to Cover ChartShort Percent of Float Chart

ENVB Short Interest Over Time

ENVB Days to Cover Over Time

ENVB Percentage of Float Shorted Over Time

Enveric Biosciences Tesla Short Interest History & Recent Changes

Export
Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
5/15/2026115,974 shares $260.94 thousand -86.9%3.2%0.29 $2.25
4/30/2026886,509 shares $3.50 million +1,306.6%45.8%0.04 $3.95
4/15/202663,023 shares $127.94 thousand -10.9%3.4%2.29 $2.03
3/31/202670,703 shares $137.16 thousand -24.8%3.8%2.22 $1.94
3/13/202693,975 shares $178.55 thousand -20.6%6.8%1.79 $1.90
2/27/2026118,369 shares $278.17 thousand +90.8%8.6%0.06 $2.35
2/13/202662,034 shares $130.27 thousand -20.0%4.5%1.31 $2.10
1/30/202677,515 shares $225.57 thousand +14.5%13.0%1.01 $2.91
1/15/202667,685 shares $276.15 thousand +7.9%11.4%1.47 $4.08
12/31/202562,720 shares $227.67 thousand -45.0%10.6%0.75 $3.63
12/15/2025114,023 shares $611.16 thousand +161.4%19.2%0.03 $5.36
11/28/202543,623 shares $254.10 thousand -39.2%7.3%1.33 $5.83
11/14/202571,782 shares $379.01 thousand +136.9%14.0%0.34 $5.28
10/31/202530,303 shares $172.73 thousand -84.9%5.9%0.66 $5.70
10/15/2025200,600 shares $180.56 thousand -35.0%3.7%0.4 $0.90
9/30/2025308,600 shares $197.32 thousand -18.3%5.7%0.8 $0.64
9/15/2025377,900 shares $355.34 thousand -5.0%13.4%1.2 $0.94
8/31/2025397,600 shares $449.29 thousand +71.1%14.1%1.9 $1.13
8/15/2025232,400 shares $255.64 thousand -8.9%8.2%1.4 $1.10
7/31/2025255,100 shares $311.22 thousand +19.5%11.9%1 $1.22
7/15/2025213,500 shares $262.61 thousand -20.6%10.0%0.9 $1.23
6/30/2025269,000 shares $325.49 thousand +17.8%12.6%1.3 $1.21
6/15/2025228,400 shares $276.36 thousand -25.0%10.7%1.1 $1.21
5/31/2025304,600 shares $356.41 thousand +143.3%14.2%1.5 $1.17
5/15/2025125,200 shares $157.75 thousand -27.2%5.9%0 $1.26
4/30/2025172,000 shares $227.04 thousand -1.3%7.0%0.1 $1.32
4/15/2025174,200 shares $216.48 thousand -3.0%7.5%0.1 $1.24
3/31/2025179,500 shares $249.51 thousand -25.6%7.7%0.1 $1.39
3/15/2025241,100 shares $417.10 thousand -80.6%13.3%0.1 $1.73
2/28/20251,240,000 shares $3.47 million +351.4%77.5%0.5 $2.80
2/15/2025274,700 shares $439.52 thousand +17.8%15.2%0.1 $1.60
1/31/2025233,200 shares $487.39 thousand -42.8%16.9%1.5 $2.09
1/15/2025407,400 shares $145.44 thousand +498.2%4.3%0.8 $0.36
12/31/202468,100 shares $24.41 thousand -56.7%0.7%0.1 $0.36
12/15/2024157,200 shares $57.14 thousand +36.1%1.7%0.3 $0.36
11/30/2024115,500 shares $38.12 thousand -57.6%1.2%0.2 $0.33
11/15/2024272,200 shares $100.71 thousand -17.6%3.0%0.5 $0.37
10/31/2024330,200 shares $164.84 thousand +70.9%4.1%0.7 $0.50
10/15/2024193,200 shares $81.72 thousand -2.9%2.4%0.1 $0.42
9/30/2024199,000 shares $94.33 thousand -2.8%2.3%0.2 $0.47
SpaceX is offering you shares. Don't take them. (Ad)

SpaceX is reserving 30% of its IPO shares for retail investors through Robinhood, Fidelity, and Schwab. But at a $1.75 trillion valuation and 266 times earnings, early institutional holders may be looking for someone to sell to. Dylan Jovine has identified a small company in Musk's supply chain that builds the power infrastructure behind Colossus - still trading at a fraction of its potential value. No IPO allocation required.tc pixel

Get the backdoor ticker free before the SpaceX IPO launches
9/15/2024204,700 shares $102.55 thousand -38.3%2.3%0.2 $0.50
8/31/2024332,000 shares $168.46 thousand -29.2%3.8%0.3 $0.51
8/15/2024469,100 shares $226.58 thousand -80.9%5.3%0.4 $0.48
7/31/20242,450,000 shares $1.15 million +1,760.3%31.2%1.7 $0.47
7/15/2024131,700 shares $71.38 thousand -13.4%1.7%0.2 $0.54
6/30/2024152,100 shares $95.25 thousand -43.4%2.0%0.3 $0.63
6/15/2024268,800 shares $198.91 thousand -20.5%3.5%0.5 $0.74
5/31/2024338,100 shares $263.72 thousand -50.2%4.5%0.2 $0.78
5/15/2024678,900 shares $534.97 thousand +736.1%8.9%0.1 $0.79
4/30/202481,200 shares $76.33 thousand -15.1%1.1%0 $0.94
4/15/202495,600 shares $88.10 thousand -62.5%1.4%0 $0.92
3/31/2024254,900 shares $254.90 thousand +69.5%4.2%0.1 $1.00
3/15/2024150,400 shares $162.43 thousand +58.2%3.2%0 $1.08
2/29/202495,100 shares $137.90 thousand +47.0%4.2%0 $1.45
2/15/202464,700 shares $54.28 thousand +181.3%2.5%0.2 $0.84
1/31/202423,000 shares $16.93 thousand -58.6%0.9%0.2 $0.74
1/15/202455,600 shares $71.17 thousand +334.4%2.3%1.4 $1.28
12/31/202312,800 shares $16.64 thousand +6.7%0.6%0.4 $1.30
12/15/202312,000 shares $16.08 thousand +263.6%0.6%0.7 $1.34
11/30/20233,300 shares $4.88 thousand -54.8%0.2%0.2 $1.48
11/15/20237,300 shares $10.40 thousand -62.4%0.4%0.4 $1.43
10/31/202319,400 shares $33.37 thousand -19.5%1.0%0.9 $1.72
10/15/202324,100 shares $50.85 thousand +121.1%1.3%0.3 $2.11
9/30/202310,900 shares $25.94 thousand -55.0%0.6%0.1 $2.38
9/15/202324,200 shares $55.18 thousand -45.3%1.2%0.3 $2.28
8/31/202344,200 shares $95.47 thousand -42.3%2.3%0.4 $2.16
8/15/202376,600 shares $182.31 thousand +86.4%4.0%0.1 $2.38
7/31/202341,100 shares $109.74 thousand +95.7%2.2%0 $2.67
7/15/202321,000 shares $60.27 thousand -43.1%1.1%0 $2.87
6/30/202336,900 shares $124.35 thousand -65.6%2.0%0 $3.37
6/15/2023107,400 shares $414.56 thousand -69.1%5.8%0 $3.86
5/31/2023347,300 shares $1.46 million +1,430.0%18.7%0.1 $4.19
5/15/202322,700 shares $34.05 thousand -30.2%1.2%0 $1.50
4/30/202332,500 shares $59.52 thousand +44.4%1.8%1 $1.83
4/15/202322,500 shares $34.20 thousand +39.8%1.2%0.6 $1.52
3/31/202316,100 shares $26.79 thousand +64.3%0.9%0.6 $1.66
3/15/20239,800 shares $16.95 thousand +71.9%0.6%0.3 $1.73
2/28/20235,700 shares $11.91 thousand -38.0%0.3%0.1 $2.09
2/15/20239,200 shares $24.93 thousand -37.8%0.5%0.2 $2.71
1/31/202314,800 shares $42.48 thousand -53.6%0.8%0.3 $2.87
1/15/202331,900 shares $90.28 thousand -21.2%1.7%0.7 $2.83
12/30/202240,500 shares $84.24 thousand -11.2%2.0%0.7 $2.08
12/15/202245,600 shares $97.58 thousand +27.4%2.3%0.9 $2.14
11/30/202235,800 shares $102.75 thousand -17.5%1.8%0.5 $2.87
11/15/202243,400 shares $147.56 thousand -37.7%2.2%0.4 $3.40
10/31/202269,700 shares $237.68 thousand +36.1%4.7%0.3 $3.41
10/15/202251,200 shares $175.10 thousand +55.2%3.6%0.1 $3.42
9/30/202233,000 shares $139.26 thousand -60.1%2.3%0.1 $4.22
9/15/202282,800 shares $477.76 thousand +11.7%5.8%0.2 $5.77
8/31/202274,100 shares $413.48 thousand -21.7%5.4%0.2 $5.58
Trump’s secret China deal (Ad)

Trump just returned from Beijing with the most powerful business delegation in American history - Elon Musk, Jensen Huang, Tim Cook, and the CEOs of BlackRock, Goldman Sachs, and CitiBank. The media covered the handshakes. But what was really being negotiated behind closed doors? Porter Stansberry has connected the Beijing trip to a landmark pact signed by 13 nations in Washington - a pact designed to cut China out of a $3 trillion investment wave tied to the most critical resource of the 21st century. His new documentary exposes the five assets at the center of it all.tc pixel

Watch the full documentary and see which assets are positioned to benefit
8/15/202294,600 shares $624.36 thousand -43.4%6.9%0.2 $6.60
7/31/2022167,000 shares $1.07 million +158.5%16.7%0.6 $6.40
7/15/202264,600 shares $25.71 million +36.6%7.5%0.8 $398.00
6/30/20222,360,000 shares $505.75 thousand -23.9%N/A0.9 $0.21
6/15/20223,100,000 shares $651 thousand -4.6%N/A1.6 $0.21
5/31/20223,250,000 shares $642.53 thousand -2.1%N/A1.5 $0.20
5/15/20223,320,000 shares $664 thousand -2.4%N/A1.1 $0.20
4/30/20223,400,000 shares $918.34 thousand +165.6%N/A1 $0.27
4/15/20221,280,000 shares $384.38 thousand -19.5%N/A0.4 $0.30
3/31/20221,590,000 shares $524.70 thousand -17.6%N/A0.6 $0.33
3/15/20221,930,000 shares $536.54 thousand +498.1%N/A0.8 $0.28
2/28/2022322,700 shares $88.58 thousand -67.6%N/A0.1 $0.27
2/15/2022996,300 shares $313.83 thousand +421.9%N/A0.8 $0.32
1/31/2022190,900 shares $121.47 thousand -67.1%N/A0.3 $0.64
1/15/2022580,200 shares $434.45 thousand +143.0%N/A0 $0.75
12/31/2021238,800 shares $222.08 thousand -41.9%N/A0.3 $0.93
12/15/2021411,300 shares $435.98 thousand -50.8%N/A0.3 $1.06
11/30/2021835,400 shares $1.09 million -45.0%4.0%0.4 $1.30
11/15/20211,520,000 shares $2.74 million -22.5%7.3%0.4 $1.80
10/29/20211,960,000 shares $3.45 million +16.0%13.8%0.5 $1.76
10/15/20211,690,000 shares $3.19 million +33.1%10.9%0.5 $1.89
9/30/20211,270,000 shares $2.63 million -44.5%8.2%0.4 $2.07
9/15/20212,290,000 shares $6.07 million +178.1%14.2%0.7 $2.65
8/31/2021823,600 shares $1.64 million -5.0%5.1%0.3 $1.99
8/13/2021866,800 shares $1.49 million -9.4%5.4%0.7 $1.72
7/30/2021956,800 shares $1.83 million +8.2%5.9%0.7 $1.91
7/15/2021884,400 shares $1.82 million +17.3%5.5%0.6 $2.06
6/30/2021754,300 shares $1.80 million +37.8%4.7%0.5 $2.38
6/15/2021547,600 shares $1.21 million -48.3%3.4%0.3 $2.21

ENVB Short Interest - Frequently Asked Questions

Short interest is the volume of Enveric Biosciences shares that have been sold short but have not yet been closed out or covered. As of May 15th, traders have sold 115,974 shares of ENVB short. 3.23% of Enveric Biosciences' shares are currently sold short. Learn More on Enveric Biosciences' current short interest.

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. ENVB shares currently have a short interest ratio of 0.3. Learn More on Enveric Biosciences's short interest ratio.

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 3.23% of Enveric Biosciences' floating shares are currently sold short.

Enveric Biosciences saw a decline in short interest in the month of May. As of May 15th, there was short interest totaling 115,974 shares, a decline of 86.9% from the previous total of 886,509 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

3.23% of Enveric Biosciences' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Enveric Biosciences: SCYNEXIS, Inc. (5.35%), Apollomics Inc. (0.15%), Senti Biosciences, Inc. (2.15%), BGM Group Ltd. (0.09%), Mainz Biomed NV (5.16%), ABVC BioPharma, Inc. (1.29%), Neuphoria Therapeutics Inc. (0.37%), Skye Bioscience, Inc. (3.85%), Lisata Therapeutics, Inc. (1.14%), Polyrizon Ltd. (2.02%),

As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($80.71 billion), Invesco QQQ ($47.96 billion), iShares Russell 2000 ETF ($22.13 billion), Western Digital Corporation ($14.35 billion), Sandisk Corporation ($12.86 billion), Salesforce Inc. ($10.89 billion), Nebius Group N.V. ($9.92 billion), SPDR S&P Biotech ETF ($9.72 billion), Lumentum Holdings Inc. ($8.89 billion), and iShares 20+ Year Treasury Bond ETF ($8.18 billion). View all of the most shorted stocks.

Short selling ENVB is an investing strategy that aims to generate trading profit from Enveric Biosciences as its price is falling. ENVB shares are trading up $0.03 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Enveric Biosciences occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of ENVB, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ENVB, twice per month. The most recent reporting period available is May, 15 2026.

Understanding short interest metrics can help you assess how traders are positioning around a stock like ENVB:

  • Shares Sold Short: The total number of shares that have been sold by short sellers but have not yet been covered or closed out. A high number may indicate bearish sentiment.
  • Short Float: The percentage of a company’s publicly available shares (or "float") that are sold short. A higher short float suggests a greater portion of the stock is being bet against.
  • Days to Cover (Short Interest Ratio): This estimates how many days it would take short sellers to cover their positions, based on average daily trading volume. Higher values can signal potential for a short squeeze if buying pressure increases.

These metrics are often used by traders to gauge sentiment, volatility risk, and the potential for price movements based on short covering activity.


Related Companies
Short Interest Tools

This page (NASDAQ:ENVB) was last updated on 6/4/2026 by MarketBeat.com Staff.
From Our Partners
How to claim a stake in SpaceX before the June 12 IPO
SpaceX is expected to go public on June 12 - and for the first time, everyday investors may have a way in befo...
Brownstone Research | Sponsoredtc pixel
Trump’s secret China deal
Trump just returned from Beijing with the most powerful business delegation in American history - Elon Musk, J...
Porter & Company | Sponsoredtc pixel
June 4: The day smart money moves (not June 12)
Everyone is watching June 12 - the SpaceX listing date. The real deadline is June 4, when Goldman Sachs, Morga...
Behind the Markets | Sponsoredtc pixel
Giving “2022 pre-ChatGPT” vibes (but 10x bigger)
When ChatGPT launched in 2022, Nvidia surged 1,800% over three years. Now, Nvidia's CEO suggests July 22nd cou...
StocksToTrade | Sponsoredtc pixel
Your $29.97 book is free today
Why Some Traders Skip Stocks Entirely You don't need a big account to trade options. In fact, options ca...
Profits Run | Sponsoredtc pixel
AI breakthrough hidden inside SpaceX exposed on June 11
On June 11, SpaceX is hosting a major investor event - and growth investor Louis Navellier believes Elon Musk ...
InvestorPlace | Sponsoredtc pixel
A Multi-Billionaire and Early Open AI Investor Just Made a Stunning Prediction
Vinod Khosla, worth $13 billion and one of OpenAI's earliest investors, just predicted that free AI doctors, t...
The Oxford Club | Sponsoredtc pixel